Dr. Rancour is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1204 MO Hwy 72
Rolla, MO 65401Phone+1 573-878-5700Fax+1 866-684-3191
Summary
- Elizabeth Rancour, MD is a board-certified dermatologist and an active member of the American Academy of Dermatology. She specializes in general, medical, and surgical dermatology, and treats patients of all ages. Dr. Rancour grew up in Saint Louis and earned her BS in biochemistry from Denison University in Granville, Ohio and her MD with distinction in both research and community service at Saint Louis University School of Medicine. She completed her dermatology residency at Indiana University School of Medicine, where she served as Chief Resident. Her interests include skin cancer, acne, rosacea, eczema, psoriasis, and many other skin conditions. Dr. Rancour is passionate about providing exceptional dermatology care for her patients, focusing on the needs of each individual to help you feel comfortable in your own skin.
Education & Training
- Indiana University School of MedicineResidency, Dermatology, 2015 - 2018
- Mercy Hospital (St Louis)Internship, Transitional Year, 2014 - 2015
- Saint Louis University School of MedicineClass of 2014
- Denison UniversityBS, Biochemistry, 2006 - 2010
- Danish Institute for Study Abroad2008
Certifications & Licensure
- MO State Medical License 2018 - 2025
- IN State Medical License 2015 - 2018
- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Chief Resident Indiana University Department of Dermatology, 2017
- Stephan Belov Award for Best Poster 21st International Workshop on Vascular Anomalies, 2016
- Arnold P. Gold Humanism Honor Society 2013
Publications & Presentations
PubMed
- 23 citationsHeight Assessments in Children With Neurofibromatosis Type 1Elizabeth A. Soucy, Dorothy van Oppen, Nicole L. Nejedly, Feng Gao, David H. Gutmann
Journal of Child Neurology. 2013-03-01 - 24 citationsDevelopmental delays in children with neurofibromatosis type 1.Elizabeth A. Soucy, Feng Gao, David H. Gutmann, Courtney M. Dunn
Journal of Child Neurology. 2012-05-01 - 14 citationsStriking enhancement at the site of radiation for nivolumab-induced Stevens-Johnson syndrome.Kishan M. Shah, Elizabeth A. Rancour, Ahmed K. Alomari, Sahand Rahnama-Moghadam
Dermatology Online Journal. 2018-06-15
Abstracts/Posters
- Sweet's Syndrome Caused by the Influenza Vaccine.Schultz K, Teijelo D, Rancour E, American Medical Women's Association 102nd Anniversary Meeting, San Francisco, CA, 1/1/2017
- Vascularized Myocutaneous Vermilion Advancement (MVA) Flap for Reconstructing Full-Thickness Lip Defects Involving the Vermilion.Rancour EA, Somani AK, American Society for Dermatologic Surgery 2016 Annual Meeting, New Orleans, LA, 1/1/2016
- When Do Hemangiomas Need Treatment? A Predictive Scoring System to Screen for Early Referral.Chamlin S, Lai JS, Beaumont J, Baselga E, Rancour E, Haggstrom A, 21st International Workshop on Vascular Anomalies, Buenos Aires, Argentina, 1/1/2016
- Join now to see all
Lectures
- Adalimumab-induced Pityriasis Lichenoides Chronica.Indianapolis, IN - 1/4/2018
- New Therapeutics in Atopic Dermatitis.Indianapolis, IN - 1/20/2017
- Localized Stevens-Johnson Syndrome Associated with Anti-PD-1 Therapy.San Diego, CA - 1/16/2017
- Join now to see all
Authored Content
- Comprehensive Dermatologic Drug Therapy - Chapter 13 Systemic CorticosteroidsMarch 2020
Professional Memberships
- Fellow
External Links
- Meramec Dermatologyhttps://www.meramecdermatology.com/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: